Matches in SemOpenAlex for { <https://semopenalex.org/work/W4292819680> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- W4292819680 endingPage "888" @default.
- W4292819680 startingPage "876" @default.
- W4292819680 abstract "Abstract: Breast cancer is the most commonly diagnosed type of cancer and ranks second among cancer that leads to death. From becoming the foremost reason for global concern, this multifactorial disease is being treated by conventional chemotherapies that are associated with severe side effects, with chemoresistance being the ruling reason. Exemestane, an aromatase inhibitor that has been approved by the US FDA for the treatment of breast cancer in post-menopausal women, acts by inhibiting the aromatase enzyme, in turn, inhibiting the production of estrogen. However, the clinical application of exemestane remains limited due to its poor aqueous solubility and low oral bioavailability. Furthermore, the treatment regimen of exemestane often leads to thinning of bone mineral density. Thymoquinone, a natural compound derived from the oil of the seeds of Nigella sativa Linn, possesses the dual property of being a chemosensitizer and chemotherapeutic agent. In addition, it has been found to exhibit potent bone protection properties, as evidenced by several studies. To mitigate the limitations associated with exemestane and to deliver to the cancerous cells overcoming chemoresistance, the present hypothesis has been put forth, wherein a natural chemosensitizer and chemotherapeutic agent thymoquinone will be incorporated into a lipid nanocarrier along with exemestane for combinatorial delivery to cancer cells. Additionally, thymoquinone being bone protecting will help in ousting the untoward effect of exemestane at the same time delivering it to the required malignant cells, safeguarding the healthy cells, reducing the offsite toxicity, and providing potent synergistic action." @default.
- W4292819680 created "2022-08-24" @default.
- W4292819680 creator A5048038480 @default.
- W4292819680 creator A5063904669 @default.
- W4292819680 creator A5064337706 @default.
- W4292819680 creator A5076644865 @default.
- W4292819680 creator A5085771499 @default.
- W4292819680 date "2023-11-01" @default.
- W4292819680 modified "2023-09-27" @default.
- W4292819680 title "Combinatorial Chemosensitive Nanomedicine Approach for the Treatment of Breast Cancer" @default.
- W4292819680 doi "https://doi.org/10.2174/1566524023666220819122948" @default.
- W4292819680 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35986537" @default.
- W4292819680 hasPublicationYear "2023" @default.
- W4292819680 type Work @default.
- W4292819680 citedByCount "2" @default.
- W4292819680 countsByYear W42928196802023 @default.
- W4292819680 crossrefType "journal-article" @default.
- W4292819680 hasAuthorship W4292819680A5048038480 @default.
- W4292819680 hasAuthorship W4292819680A5063904669 @default.
- W4292819680 hasAuthorship W4292819680A5064337706 @default.
- W4292819680 hasAuthorship W4292819680A5076644865 @default.
- W4292819680 hasAuthorship W4292819680A5085771499 @default.
- W4292819680 hasConcept C109316439 @default.
- W4292819680 hasConcept C121608353 @default.
- W4292819680 hasConcept C126322002 @default.
- W4292819680 hasConcept C185592680 @default.
- W4292819680 hasConcept C202751555 @default.
- W4292819680 hasConcept C2775860665 @default.
- W4292819680 hasConcept C2776166826 @default.
- W4292819680 hasConcept C2776375370 @default.
- W4292819680 hasConcept C2778004101 @default.
- W4292819680 hasConcept C2779034068 @default.
- W4292819680 hasConcept C2779699572 @default.
- W4292819680 hasConcept C502942594 @default.
- W4292819680 hasConcept C530470458 @default.
- W4292819680 hasConcept C55493867 @default.
- W4292819680 hasConcept C71924100 @default.
- W4292819680 hasConcept C98274493 @default.
- W4292819680 hasConceptScore W4292819680C109316439 @default.
- W4292819680 hasConceptScore W4292819680C121608353 @default.
- W4292819680 hasConceptScore W4292819680C126322002 @default.
- W4292819680 hasConceptScore W4292819680C185592680 @default.
- W4292819680 hasConceptScore W4292819680C202751555 @default.
- W4292819680 hasConceptScore W4292819680C2775860665 @default.
- W4292819680 hasConceptScore W4292819680C2776166826 @default.
- W4292819680 hasConceptScore W4292819680C2776375370 @default.
- W4292819680 hasConceptScore W4292819680C2778004101 @default.
- W4292819680 hasConceptScore W4292819680C2779034068 @default.
- W4292819680 hasConceptScore W4292819680C2779699572 @default.
- W4292819680 hasConceptScore W4292819680C502942594 @default.
- W4292819680 hasConceptScore W4292819680C530470458 @default.
- W4292819680 hasConceptScore W4292819680C55493867 @default.
- W4292819680 hasConceptScore W4292819680C71924100 @default.
- W4292819680 hasConceptScore W4292819680C98274493 @default.
- W4292819680 hasIssue "9" @default.
- W4292819680 hasLocation W42928196801 @default.
- W4292819680 hasLocation W42928196802 @default.
- W4292819680 hasOpenAccess W4292819680 @default.
- W4292819680 hasPrimaryLocation W42928196801 @default.
- W4292819680 hasRelatedWork W2020725023 @default.
- W4292819680 hasRelatedWork W2103037308 @default.
- W4292819680 hasRelatedWork W2127263354 @default.
- W4292819680 hasRelatedWork W2134223006 @default.
- W4292819680 hasRelatedWork W2410444284 @default.
- W4292819680 hasRelatedWork W2516173202 @default.
- W4292819680 hasRelatedWork W2597671439 @default.
- W4292819680 hasRelatedWork W2947503151 @default.
- W4292819680 hasRelatedWork W4292819680 @default.
- W4292819680 hasRelatedWork W4385199929 @default.
- W4292819680 hasVolume "23" @default.
- W4292819680 isParatext "false" @default.
- W4292819680 isRetracted "false" @default.
- W4292819680 workType "article" @default.